USING KETAMINE FOR CHRONIC PAIN IN AUSTRALIA: SAFE OR NOT?
INTRODUCTION: KETAMINE’S EMERGING ROLE IN PAIN MANAGEMENT
Chronic pain affects nearly one in five Australians, and for many, conventional treatments simply don’t work. As a result, both patients and clinicians have begun exploring alternative therapies. One such option gaining popularity is ketamine. Known primarily as an anaesthetic, ketamine is increasingly being used to manage chronic pain in Australia. But is it safe?
This article explores the current landscape of ketamine therapy for chronic pain in Australia, including its safety profile, effectiveness, legal status, and where patients can access treatment.
WHAT IS KETAMINE AND HOW DOES IT WORK?
AN OVERVIEW OF KETAMINE
Ketamine is a dissociative anaesthetic originally developed in the 1960s. It has been used in medical settings for decades to provide pain relief and sedation. Unlike opioids, which target opioid receptors, ketamine works through the NMDA (N-methyl-D-aspartate) receptors in the brain. This distinction makes it a valuable tool for patients with opioid resistance or opioid-induced hyperalgesia.
KETAMINE’S MECHANISM FOR PAIN RELIEF
Ketamine interrupts the transmission of pain signals by blocking NMDA receptors. This can lead to rapid and sometimes long-lasting pain relief. Additionally, ketamine is known to have anti-inflammatory effects and may promote nerve healing in some cases. Because of these characteristics, it is often used for complex regional pain syndrome (CRPS), neuropathic pain, fibromyalgia, and cancer-related pain.
WHO MIGHT BENEFIT FROM KETAMINE FOR PAIN?
CONDITIONS TREATED WITH KETAMINE IN AUSTRALIA
In Australia, pain specialists consider ketamine therapy for individuals with:
- Chronic neuropathic pain
- CRPS
- Phantom limb pain
- Cancer-related pain
- Fibromyalgia
- Refractory migraines
Many of these patients have exhausted traditional medications such as NSAIDs, antidepressants, anticonvulsants, or opioids. Ketamine offers an alternative when those options fail.
PATIENT PROFILES AND SELECTION CRITERIA
Not everyone qualifies for ketamine therapy. Australian clinics generally assess patients based on:
- Severity and duration of pain
- Past treatment history
- Mental health status
- Risk factors for substance misuse
- Current medications
Patients must undergo psychiatric screening to ensure they are not at high risk of adverse psychological reactions.
HOW KETAMINE IS ADMINISTERED FOR CHRONIC PAIN
IV INFUSION THERAPY
The most common method in Australia is intravenous (IV) infusion. Infusions are conducted in controlled environments, typically in private pain clinics or hospital pain units. A typical course may include several sessions over one to two weeks.
OTHER ROUTES: ORAL, NASAL, AND SUBCUTANEOUS
Though IV is most common, some clinics offer oral lozenges or nasal sprays for home use after initial supervision. Subcutaneous injections are also occasionally used, particularly in palliative care. However, these alternatives often come with lower efficacy and higher variability in absorption.
WHERE TO ACCESS KETAMINE THERAPY IN AUSTRALIA
LOCATIONS OFFERING KETAMINE FOR PAIN
Ketamine for chronic pain is available in major cities across Australia, including:
- Sydney: Private pain clinics and university hospitals
- Melbourne: Specialist centres and integrative medicine practices
- Brisbane: Multidisciplinary pain units and psychiatric clinics
- Perth and Adelaide: Public hospitals and some private offerings
Some regional centres have telehealth consultations, but patients often must travel to urban clinics for infusion sessions.
REFERRAL AND PRESCRIPTION PROCESS
To begin ketamine therapy, patients typically need a referral from a GP or pain specialist. Clinics assess eligibility and monitor closely for side effects or misuse potential. Many treatments are off-label, meaning doctors prescribe them based on evidence rather than formal drug registration for that condition.
IS KETAMINE LEGAL FOR PAIN MANAGEMENT IN AUSTRALIA?
SCHEDULE 8 CONTROLLED MEDICINE
In Australia, ketamine is classified as a Schedule 8 controlled substance under the Poisons Standard. While legal for medical use, it is strictly regulated. Only authorised practitioners can prescribe it, and often a state-level permit is required.
TGA AND OFF-LABEL USE
The Therapeutic Goods Administration (TGA) allows ketamine to be prescribed off-label for chronic pain, though each state has different reporting requirements. The legal framework ensures careful monitoring but can also delay access for patients in urgent need.
SAFETY AND RISKS OF KETAMINE FOR CHRONIC PAIN
COMMON SIDE EFFECTS
When used appropriately, ketamine is generally safe. However, patients may experience:
- Drowsiness
- Dizziness
- Nausea
- Elevated blood pressure
- Dissociation or hallucinations (more likely at high doses)
These side effects are typically short-lived and monitored during treatment.
LONG-TERM SAFETY CONCERNS
Long-term use, especially at high doses or without medical supervision, can lead to bladder dysfunction (ketamine cystitis), cognitive impairment, or dependency. In Australia, these risks are minimised by limiting use to licensed clinics with strict protocols.
COMPARING KETAMINE TO OTHER CHRONIC PAIN TREATMENTS
OPIOIDS VS. KETAMINE
Opioids remain the most common treatment for chronic pain in Australia. However, they carry a high risk of tolerance, addiction, and overdose. Ketamine, by contrast, does not cause respiratory depression and has a lower addiction potential when used responsibly.
PSYCHOTHERAPY AND MULTIMODAL APPROACHES
Many pain clinics combine ketamine therapy with cognitive behavioural therapy (CBT), physiotherapy, and mindfulness training. This holistic model appears to improve outcomes and reduce reliance on medications alone.
COST OF KETAMINE THERAPY IN AUSTRALIA
OUT-OF-POCKET EXPENSES
Ketamine treatment is not currently subsidised by Medicare for chronic pain. Patients must often pay out of pocket, with costs ranging from:
- $400–$800 per IV infusion
- $200–$500 for follow-up sessions
- $100–$300 for oral/nasal ketamine prescriptions
Private health insurance may cover parts of the consultation or inpatient care but rarely covers the medication itself.
IS IT WORTH THE COST?
Many patients report substantial relief after ketamine therapy, even when nothing else worked. While costly, the potential to regain mobility, reduce opioid use, and improve quality of life can justify the investment for those who benefit.
RESEARCH AND FUTURE DIRECTIONS
GROWING EVIDENCE BASE
Australian and international studies continue to investigate ketamine’s role in pain management. Researchers at institutions like UNSW and Monash University are evaluating long-term outcomes, safety, and comparative effectiveness.
INTEGRATION INTO STANDARD CARE
If future trials confirm ketamine’s benefits, it may eventually become a mainstream treatment. Efforts are underway to include it in national pain guidelines and expand access through public health services.
FINAL THOUGHTS: IS KETAMINE SAFE FOR CHRONIC PAIN?
When used under expert supervision, ketamine appears to be a promising and relatively safe option for chronic pain in Australia. It is not a miracle drug, but for many patients, it offers real hope. Careful screening, structured programs, and ongoing monitoring help ensure the therapy remains beneficial without undue risk.